1h Free Analyst Time
The cmo in pharmaceutical industry market is forecasted to grow by USD 42.7 million during 2024-2029, accelerating at a CAGR of 6.5% during the forecast period. The report on the cmo in pharmaceutical industry market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of cost-efficient resources in emerging markets, growing need to focus on core competencies, and strong research funding.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The cmo in pharmaceutical industry market is segmented as below:
By Service
- API manufacturing
- FDF manufacturing
By Drug Class
- Small molecule
- Drugs biologics
- High potency drugs
By End-user
- Big pharma
- Small and medium enterprises (SMEs)
- Generic drug manufacturers
- Biotech companies
By Geographical Landscape
- Europe
- North America
- APAC
- Middle East and Africa
- South America
The report on the cmo in pharmaceutical industry market covers the following areas:
- CMO In Pharmaceutical Industry Market sizing
- CMO In Pharmaceutical Industry Market forecast
- CMO In Pharmaceutical Industry Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Service
9 Market Segmentation by Drug Class
10 Market Segmentation by End-user
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global CMO in pharmaceutical industry market: Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Cambrex Corp., Catalent Inc., Chongqing Huapont Pharmaceutical Co. Ltd., Cipla Inc., Cmic Holdings Co. Ltd, Curia Global Inc., DR Reddys Laboratories Ltd., FAMAR Health Care Services, Jubilant Pharma Ltd., Lonza Group Ltd., Lupin Ltd., PCI Pharma Services, Pfizer Inc., Recipharm AB, Samsung Biologics Co. Ltd., Thermo Fisher Scientific Inc., and Vetter Pharma Fertigung GmbH and Co. KG.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is US FDA-approved manufacturing facilities."
According to the report, one of the major drivers for this market is the availability of cost-efficient resources in emerging markets.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Almac Group Ltd.
- Boehringer Ingelheim International GmbH
- Cadila Pharmaceuticals Ltd.
- Cambrex Corp.
- Catalent Inc.
- Chongqing Huapont Pharmaceutical Co. Ltd.
- Cipla Inc.
- Cmic Holdings Co. Ltd
- Curia Global Inc.
- Dr Reddys Laboratories Ltd.
- FAMAR Health Care Services
- Jubilant Pharma Ltd.
- Lonza Group Ltd.
- Lupin Ltd.
- PCI Pharma Services
- Pfizer Inc.
- Recipharm AB
- Samsung Biologics Co. Ltd.
- Thermo Fisher Scientific Inc.
- Vetter Pharma Fertigung GmbH and Co. KG
